A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old, before menopause.
- You have untreated bacterial vaginosis with a fishy odor or unusual discharge, confirmed by a doctor's test.
- Your body mass index (BMI) is 37 or lower.
- You are willing to stop vaginal intercourse, use of tampons, menstrual cups, and other vaginal products for a short time during the trial.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 6 months.
- You have not used antibiotics in the vagina or by mouth in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.
This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.
This study tests whether a probiotic product called Gyntima Balance can help prevent bacterial vaginosis (BV)—a common vaginal infection—from coming back repeatedly. If it works, it could reduce uncomfortable symptoms and the need for repeated antibiotic treatments.
This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
Hear when a new Bacterial Vaginosis (BV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.